Optimized dosing for drug coated stents

Details for Australian Patent Application No. 2002336764 (hide)

Owner Boston Scientific Limited

Inventors Barry, James, J.; Kamath, Kalpana, R.

Agent Shelston IP

Pub. Number AU-B-2002336764

PCT Number PCT/US02/30193

PCT Pub. Number WO2003/035135

Priority 60/324,095 24.09.01 US

Filing date 24 September 2002

Wipo publication date 6 May 2003

Acceptance publication date 29 March 2007

International Classifications

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61F 2/84 (2006.01) Filters

A61L 31/16 (2006.01) Materials for other surgical articles

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

20 February 2003 Complete Application Filed

  Priority application(s): 60/324,095 24.09.01 US

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002336764

2 March 2006 Assignment before Grant

  Scimed Life Systems, Inc. The application has been assigned to Boston Scientific Limited

29 March 2007 Application Accepted

  Published as AU-B-2002336764

2 August 2007 Standard Patent Sealed

22 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002336765-Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder

2002336763-PSA PROCESS FOR COPRODUCING NITROGEN AND OXYGEN